19 Sep 2017 07:00
19 September 2017
Sphere Medical Holding plc
("Sphere", "Sphere Medical" or the "Company")
Cancellation of AIM listing
Sphere Medical Holding plc (AIM: SPHR.L), an innovative point-of-care monitoring and diagnostic devices company, announces that, further to the announcement on 8 September 2017, pursuant to Rule 41 of the AIM Rules for Companies the Company's admission to trading on AIM will be cancelled with effect from 7.00 am BST tomorrow, 20 September 2017.
The capitalised terms used in this announcement have the meaning as defined in the announcement published by the Company at 5:53 p.m. on 21 August 2017 unless otherwise stated.
- Ends -
For further information, please contact:
Sphere Medical Holding plc | Tel: +44 (0)1223 875 222 | |
Dr Wolfgang Rencken, Chief Executive Officer | ||
Richard Wright, Chief Financial Officer | ||
Panmure Gordon | Tel: +44 (0) 20 7886 2500 | |
Freddy Crossley (Corporate Finance) | ||
Duncan Monteith (Corporate Finance) | ||
Tom Salvesen (Corporate Broking) | ||
Consilium Strategic Communications | Tel: +44 (0) 20 3709 5700 | |
Mary-Jane Elliott | spheremedical@consilium-comms.com | |
Ivar Milligan | ||
Hendrik Thys | ||
Notes for Editors
About Sphere Medical (AIM: SPHR.L)
Sphere Medical is an innovative point-of-care medical device company. Its Proxima platform measures blood gases, electrolytes and metabolites at the patient's bedside and aims to improve patient care and reduce health system costs. For further information, please visit www.spheremedical.com.
Sphere Medical Holding (SPHR)